U
Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
D
Sell
1/10/2017Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 1/10/2017 due to a decline in the total return index and volatility index.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 1/10/2017 due to a decline in the total return index and volatility index.
D
Sell
10/31/2016Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 10/31/2016 due to an increase in the total return index and valuation index.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 10/31/2016 due to an increase in the total return index and valuation index.
D
Sell
5/19/2016Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 5/19/2016 due to a decline in the volatility index and valuation index.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 5/19/2016 due to a decline in the volatility index and valuation index.
D
Sell
4/29/2016Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 4/29/2016 due to a noticeable increase in the growth index, volatility index and efficiency index.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 4/29/2016 due to a noticeable increase in the growth index, volatility index and efficiency index.
D
Sell
3/11/2016Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
C
Hold
3/8/2016Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C from C- on 3/8/2016 due to an increase in the total return index and volatility index.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C from C- on 3/8/2016 due to an increase in the total return index and volatility index.
C
Hold
1/12/2016Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to C- from C on 1/12/2016 due to a decline in the total return index.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to C- from C on 1/12/2016 due to a decline in the total return index.
C
Hold
12/28/2015Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C from C- on 12/28/2015 due to an increase in the total return index and efficiency index. Total capital increased 3.92% from -$6.84M to -$7.11M.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C from C- on 12/28/2015 due to an increase in the total return index and efficiency index. Total capital increased 3.92% from -$6.84M to -$7.11M.
C
Hold
8/17/2015Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C- from D on 8/17/2015 due to a significant increase in the efficiency index and valuation index. Total capital increased 9.23% from -$6.27M to -$6.84M.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C- from D on 8/17/2015 due to a significant increase in the efficiency index and valuation index. Total capital increased 9.23% from -$6.27M to -$6.84M.
D
Sell
4/16/2015Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 4/16/2015 due to a decline in the efficiency index and solvency index. The quick ratio declined from 0.02 to 0.02.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 4/16/2015 due to a decline in the efficiency index and solvency index. The quick ratio declined from 0.02 to 0.02.
D
Sell
3/23/2015Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 3/23/2015 due to an increase in the valuation index.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 3/23/2015 due to an increase in the valuation index.
D
Sell
3/6/2015Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 3/6/2015 due to a decline in the valuation index.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 3/6/2015 due to a decline in the valuation index.
D
Sell
2/19/2015Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 2/19/2015 due to an increase in the valuation index.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 2/19/2015 due to an increase in the valuation index.
D
Sell
2/4/2015Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 2/4/2015 due to a decline in the total return index and valuation index.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 2/4/2015 due to a decline in the total return index and valuation index.
D
Sell
1/20/2015Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 1/20/2015 due to an increase in the volatility index, total return index and valuation index.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 1/20/2015 due to an increase in the volatility index, total return index and valuation index.
D
Sell
11/14/2014Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 11/14/2014 due to a major decline in the growth index, efficiency index and solvency index. Operating cash flow declined 56.18% from $430.2 to $188.5, the quick ratio declined from 0.04 to 0.02, and total revenue declined 24.64% from $2.22M to $1.67M.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D from D+ on 11/14/2014 due to a major decline in the growth index, efficiency index and solvency index. Operating cash flow declined 56.18% from $430.2 to $188.5, the quick ratio declined from 0.04 to 0.02, and total revenue declined 24.64% from $2.22M to $1.67M.
D
Sell
8/15/2014Downgrade
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D+ from C- on 8/15/2014 due to a significant decline in the efficiency index and valuation index. Net income declined 56.57% from -$974.5 to -$423.2.
Targeted Medical Pharma, Inc. (TRGM) was downgraded to D+ from C- on 8/15/2014 due to a significant decline in the efficiency index and valuation index. Net income declined 56.57% from -$974.5 to -$423.2.
C
Hold
8/1/2014Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C- from D+ on 08/01/2014.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to C- from D+ on 08/01/2014.
D
Sell
5/1/2014Upgraded
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 5/1/2014 due to a significant increase in the efficiency index, valuation index and growth index. Total revenue increased 19.97% from $2.19M to $2.63M.
Targeted Medical Pharma, Inc. (TRGM) was upgraded to D+ from D on 5/1/2014 due to a significant increase in the efficiency index, valuation index and growth index. Total revenue increased 19.97% from $2.19M to $2.63M.
OTC PK
02/25/2025 1:53PM Eastern
Quotes delayed
